NFKB1 and atopic eczema: Properly speaking, it was able to restrain phosphorylation of MAPK and NF-κB in skin tissue, decrease the levels of interleukin-4 and IgE in serum, and reduce the expression level of various inflammation-related cytokines, thereby ameliorating the skin condition of atopic dermatitis (Lee et al., 2019).